Form 4: Guardant Health Chief Medical Officer Awarded Stock Options and Restricted Stock Units
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, was granted stock options and restricted stock units on November 8, 2024, as part of his compensation.
Summary
- Craig Eagle, the Chief Medical Officer of Guardant Health, received a stock option award for 47,627 shares at an exercise price of $28.61 on November 8, 2024.
- The stock options vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting in equal monthly installments over the following two years.
- Mr. Eagle also received a restricted stock unit (RSU) award for 31,751 shares on the same date.
- The RSUs also vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting in equal quarterly installments over the following two years.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management interests with shareholders. There is no indication of any negative issues.
Positives
- The granting of stock options and RSUs aligns the Chief Medical Officer's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
The granting of stock options and restricted stock units is a common practice in the biotechnology and healthcare industry to incentivize and retain key executives.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices for executives in the biotech industry, similar to companies like Exact Sciences and Illumina.
- The vesting schedules are also typical, with a mix of cliff vesting and subsequent periodic vesting to encourage long-term performance.
Stakeholder Impact
- Shareholders may view the grants positively as they incentivize management to increase the company's value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 11/08/2024 | Date of grant for both stock options and restricted stock units. |
| 10/01/2025 | Initial vesting date for 33% of both stock options and restricted stock units. |
Keywords
stock options, restricted stock units, executive compensation, vesting, Guardant Health, Craig Eagle, equity awards
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.